2021 Evidence briefings
These evidence briefs aim to support health professionals to review the latest evidence against their current practice in relation to medication safety interventions.
These evidence briefs aim to support health professionals to review the latest evidence against their current practice in relation to medication safety interventions.
Health service organisations that wish to purchase their own licence to continue using the MSSA® may visit the Institute of Safe Medication Practices (ISMP) Canada’s MSSA® webpage for further information.&nb
The National Guidelines for On-Screen Display of Medicines Information provide an evidence-based approach to on-screen presentation of medicines information. They:
Revised EMM Self-Assessment Tool
The Commission has released an updated Electronic Medication Management Self-Assessment Tool (EMMSAT) to assist health services with independent assessment and optimisation of their EMM system implementation.
New resources
The List aims to:
The Perioperative labelling poster describes user-applied labelling of medicines and fluids in closed-and open-practice perioperative areas.
The Commission developed the National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines (the Labelling Standard) for health professionals to communicate safely: